Cannabidiol CBD Clinical Research

Cannabidiol (CBD)

NOTABLE CANNABIDIOL SCIENCE:

 

Assessing the Effects of a Cannabidiol Derived From Hemp Supplement in Healthy Adults

by Shawn M. Arent, University of South Carolina | January 28, 2022 | ClinicalTrials.gov | Full Text CBD and Morphene

Evaluation of the Interactions of Cannabidiol CBD With Morphine

National Institute on Drug Abuse (NIDA) | December 3, 2021 | ClinicalTrials.gov | Full Text CBD and Parkinsons

Effect of Medical Cannabis for Non-motor Symptoms of Parkinson's Disease

Dr. Saar Anis, Sheba Medical Center | November 3, 2021 | ClinicalTrials.gov | Full Text CBD and Neuroinflation

Cannabidiol for Reduction of Brain Neuroinflammation CBD

Jodi Gilman, Massachusetts General Hospital | October 4, 2021 | ClinicalTrials.gov | Full Text CBD Antioxidative Properties

Antioxidative and Anti-Inflammatory Properties of Cannabidiol

by Sinemyiz Atalay, Iwona Jarocka-Karpowicz and Elzbieta Skrzydlewska | December 25, 2019 | Antioxidants 2020 | Full Text CBD Neurological Aspects

Neurological Aspects of Medical Use of Cannabidiol

by Carmen Mannucci, Michele Navarra, Fabrizio Calapai1, Elvira Ventura Spagnolo,Francesco Paolo Busardò, Roberto Da Cas, Francesca Menniti Ippolito and Gioacchino Calapai1 | March 8, 2007 | CNS & Neurological Disorders - Drug Targets, 2017 | Full Text CBD Clinical Trials

Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers

Alix Morel1, Pierre Lebard1, Alexandra Dereux, Julien Azuar, Frank Questel, Frank Bellivier, Cynthia Marie-Claire, Mélina Fatséas, Florence Vorspan, Vanessa Bloch | February 22, 2021 | Frontiers in Psychiatry | Full Text